Présentation

The Institute for Neurosciences of Montpellier (INM) concentrates basic research for studying transduction, integration and disorders of sensory and motor systems. The INM houses several teams working on vision, hearing, somatosensory wiring, and myelination. Molecular to systems level investigations are carried-out through core technical facilities at the INM. Our outputs favor the development of new treatments for sensory and motor deficits, with the strong interest on inherited retinal and optic blindness, auditory neuropathies (deafness and tinnitus), neurodegenerative diseases (amyotrophic lateral sclerosis, giant axonal neuropathy), sensitivity disorders (touch and pain) and glial pathologies (gliomas and Charcot Marie Tooth disease).

The project is based on five 5 labelled-Inserm teams (C. Hamel, J.L. Puel, P. Carroll, H. Duffau and Cédric Raoul). In addition, the INM houses 2 Atip/Avenir groups (Nicolas Tricaud -ERC awarded- and Pascale Bomont).

 The research teams are organized around technical facilities (core facilities) dedicated to functional (animal care, RAM network), histological (RHEM), and cell imaging. (Rio-Imaging-IBiSA). We actively participated in the creation of the BioNanoNMRI platform (small animal-dedicated fMRI: Agilent-Varian 9.4T).

Venir à l'INM

Hôpital Saint Eloi - Bâtiment INM
80, rue Augustin Fliche - BP 74103
34091 Montpellier cedex 5 - France
Tel.: (33) (0)4 99 63 60 00
Fax: (33) (0)4 99 63 60 20

Plan INM1. En venant de Lyon ou de Barcelone, prendre la sortie Montpellier Est (A9), suivre la direction "centre ville", puis la direction "Hôpitaux-Facultés". Enfin, prendre la direction "Hôpital Gui de Chauliac-St-Eloi". Entrer par l'entrée principale du campus du CHU (rue Augustin Fliche), se garer au fond du campus.

 

2. En arrivant en train ou par la navette de l'aéroport, prendre le tramway n°1, arrêt Saint-Eloi. Remonter la rue Emile Bertin Sans jusqu'au portail situé à 200 m, tourner directement dans l'allée de droite sur 200 m.

 

 

 

Partenariats

The INM belongs to the labEX “Epigenmed” and to EuroBiomed, the Pole of Excellence dedicated to rare diseases. We strengthen the development of new therapeutic molecules through a partnership with the National graduate school of chemistry of Montpellier and SANOFI. We are actively involved in the set-up of the Medical Health Cluster of Montpellier (Pole Rabelais Biologie-Santé). Partnership with the future “Université Sud de France” provides PhD students with a deep understanding in the field of Biology/Health. The number of masters and PhD degrees from the INM demonstrates the breadth of our students' research, spanning engineering/physical sciences, basic biological sciences and clinical sciences (32 master and 22 PhD students, and 10 post docs in average per year).


During the last four years, U1051 developed scientific cooperations with private companies (Sanofi, Cellectis). In addition, several researchers are consultants in private companies (Soffinova partner, BetaInnov, Sensorion, Biolux or Sanofi). This led to 9 patents (Inserm or CNRS) deposited in partnership with private companies since 2008. We are also involved in the EuroBioMed pole of competitivity (Eurocom for cochlea implant).